Skip to content

Correlation Study of Vascular Parameters in Hypertensive Men With Erectile Dysfunction

Correlation of Flow Mediated Dilation of Brachial Artery and Carotid Intima Media Thickness With Erectile Dysfunction Severity and Clinical Response to PDE 5 Inhibitor in Hypertensive Men

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01084187
Enrollment
100
Registered
2010-03-10
Start date
2010-01-31
Completion date
2011-02-28
Last updated
2011-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Arterial Hypertension, Endothelial Dysfunction, Erectile Dysfunction

Keywords

erectile dysfunction, arterial hypertension, flow mediated vasodilation, endothelial dysfunction, carotid intima media thickness, vardenafil

Brief summary

The purpose of the study is to assess the correlation of FMD of brachial artery and carotid intima media thickness with ED severity and clinical response to vardenafil in hypertensive men.

Detailed description

To achieve this objective, a prospective study will be conducted, with hypertensive patients ranging from 50 to 70 years, presenting vasculogenic erectile dysfunction for over six months and sexually actives. All patients will be assessed for clinical and laboratorial data, endothelial dysfunction, endothelium independent vasodilation and carotid intima media thickness at the inclusion of the study. They will receive medical orientations from the same urologist and will return after four attempts with 20 mg of vardenafil.

Interventions

vardenafil 20 mg on demand or vardenafil daily or placebo

Sponsors

Hospital Universitario Pedro Ernesto
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
MALE
Age
50 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* arterial hypertension and erectile dysfunction of vascular origin for at least 6 month

Exclusion criteria

* other condition that cause erectile dysfunction such as depression, hypogonadism, surgery, trauma, major cardiovascular event

Design outcomes

Primary

MeasureTime frameDescription
clinical response to vardenafilfour weeksSEP 2; SEP 3 and IIEF variation

Secondary

MeasureTime frameDescription
endothelial dysfunctionfour weeksvariation of FMD of brachial artery from baseline

Countries

Brazil

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026